Adaptive Biotechnologies Corp (ADPT) concluded trading on Thursday at a closing price of $4.90, with 4.88 million shares of worth about $23.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 69.55% during that period and on September 26, 2024 the price saw a gain of about 22.50%. Currently the company’s common shares owned by public are about 145.08M shares, out of which, 142.33M shares are available for trading.
Stock saw a price change of 2.51% in past 5 days and over the past one month there was a price change of 5.60%. Year-to-date (YTD), ADPT shares are showing a performance of 0.00% which decreased to -11.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.28 but also hit the highest price of $6.34 during that period. The average intraday trading volume for Adaptive Biotechnologies Corp shares is 1.24 million. The stock is currently trading 10.30% above its 20-day simple moving average (SMA20), while that difference is up 9.91% for SMA50 and it goes to 26.72% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adaptive Biotechnologies Corp (NASDAQ: ADPT) currently have 145.08M outstanding shares and institutions hold larger chunk of about 96.48% of that.
The stock has a current market capitalization of $722.60M and its 3Y-monthly beta is at 1.43. It has posted earnings per share of -$1.47 in the same period. It has Quick Ratio of 3.84 while making debt-to-equity ratio of 0.94. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ADPT, volatility over the week remained 12.12% while standing at 7.54% over the month.
Stock’s fiscal year EPS is expected to rise by 22.04% while it is estimated to increase by 15.62% in next year. EPS is likely to grow at an annualized rate of 21.60% for next 5-years, compared to annual growth of -32.91% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on July 05, 2023 offering an Overweight rating for the stock and assigned a target price of $15 to it. Coverage by Scotiabank stated Adaptive Biotechnologies Corp (ADPT) stock as a Sector outperform in their note to investors on January 05, 2023, suggesting a price target of $15 for the stock. On December 21, 2022, Piper Sandler Upgrade their recommendations, while on August 25, 2022, Credit Suisse Initiated their ratings for the stock with a price target of $8. Stock get a Neutral rating from Piper Sandler on June 03, 2022.
